Selected aspects of pre-clinical diagnosis of posterior cranial fossa tumours in children at paediatric departments of district hospitals in Lesser Poland and Podkarpacie
Keywords:
brain tumour, posterior cranial fossa tumour, symptoms, atypical symptoms, oncological vigilanceAbstract
Enormous progress has been made in a diagnosis of central nervous system (CNS) tumours in the past dozen or so years. Computed tomography (CT) and magnetic resonance (MR) made that progress possible. Those methods facilitate an early and accurate diagnosis of most of CNS tumours. Yet modern imaging methods cannot replace a detailed subjective assessment of a patient’s medical history and a neurological examination. The knowledge of the symptoms and the circumstances in which they occur makes a precise diagnosis possible. Data showed that only 24 percent of paediatricians moved the diagnostic process in the right direction after their first contact with a patient. Delays in diagnosing a brain tumour usually mean a more extensive surgery, often without the possibility of complete removal of tumour tissue, and postoperative complications. The aim of this study was the examination of the diagnostic process of posterior cranial fossa tumour in children from primary care through department of paediatrics to department of neurosurgery. The study focused on the correlation between the demographic and educational factors and between the accuracy and promptness of a diagnostic decision. It checked oncological vigilance of doctors. Major difficulties in CNS tumour diagnosis are: 1. Low incidence of such cases in paediatric practice. 2. Absence of oncological vigilance. 3. Misinterpretation of symptoms such as morning headaches and vomiting. 4. Exclusion of rare symptoms such as neck pain, little educational progress, emotional changes. Imaging methods (CT and MR) are widely available and have no influence on the CNS tumours diagnosis.
Downloads
References
Perek D, Roszkowski M. Nowotwory ośrodkowego układu nerwowego. Diagnostyka i leczenie. Fundacja Neuronet 2006;(308).
Zając A, Gergont A, Kroczka-Wesołowska E. Manifestacja kliniczna nowotworów mózgowia wśród dzieci hospitalizowanych w klinice neurologii dziecięcej. Przegl.Lek. 2008;65(11):813–8. Pediatr. Pol. 1995 Mar; 70(3):219–23.
Dzianott A, Korczowski R, Czyżyk E, Mazur A. Analiza guzów mózgu u dzieci z regionu rzeszowskiego. Pediatr Pol. 1995 Mar;70(3):219–23.
Jacobi A. The history of pediatrics and its relation to other sciences and arts. Arch Pediatr. 1951 Apr;68(4):179–96.
Reulecke BC. Erker CG., Fiedler BJ. Et al. Brain tumors in children: initial symptoms and their influence on the time span between symptom onset and diagnosis. J. Child Neurol. 2008;23:178.
Zakrzewski K, Fiks T, Liberski P.P. Nowotwory ośrodkowego układu nerwowego u dzieci i młodzieży. Pediatr. Pol. 2005 .
Perek D. Nowotwory mózgu u dzieci – wyzwanie nie tylko dla onkologów. Ped. Pol. 2005;80:11.
Roszkowski M. Nowotwory mózgu u dzieci. Postępy w diagnostyce i leczeniu chorób układu nerwowego u dzieci. Jóźwiak S. (red.). Wyd. Biforium.
Perek D, Perek-Polnik M. Guzy mózgu u dzieci. Przegl. Lek. 2003;60:(Supl.)5.
Kałuża J. O niektórych odrębnościach nowotworów ośrodkowego układu nerwowego wieku dziecięcego. 219-23. Neur. Dziec. 2003;23.
Hayashia N, Kidokoroa H, Miyajimaa Y, Fukazawaa T, Natsumeb J, Kubotaa T, Kojimab S. How do the clinical features of brain tumors in childhood progress before diagnosis? Brain and Development 2010 Sept;32:8.
Wilne SH, Ferris RC, Nathwani A, Kennedy CR. To determine the presenting features of brain tumours in children. Archives of Disease in Childhood 2006;91(6).
Mehta, Vivek M.D., M.Sc.; Chapman, Ann R.N.; McNeely, P. Daniel M.D.; Walling, Simon M.D.; Howes, William J. M.D.: Latency between Symptom Onset and Diagnosis of Pediatric Brain Tumors. An Eastern Canadian Geographic Study Neurosurgery 2002;51(2).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2011 Medical Journal of the Rzeszow University and the National Medicines Institute, Warsaw

This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.




